ANTICOAGULANT MARKET ANALYSIS

Anticoagulant Market, By Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low-molecular- weight Heparin(LMWH), and Vitamin K Antagonist), By Application (Atrial Fibrillation/Myocardial Infarction (Heart Attack), Deep Vein Thrombosis (DVT), Pulmonary Embolism, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5486
Pages :169
Formats :
Excel and PDF
Industry : Pharmaceutical

Anticoagulant MarketSize and Trends

The global anticoagulant market was valued at US$ 30,773.2 Mn in 2021 and is forecast to reach a value of US$ 57,337.5 Mn by 2028 at a CAGR of 9.4% between 2022 and 2028. The anticoagulant market is experiencing strong growth due to the growing prevalence of chronic disease and rise in demand for anticoagulants across the world. Moreover, rise in focus on the development of novel anticoagulants and growing geriatric population across the globe are expected to boost the growth of the market. However, factors such as side effects associated with anticoagulants and stringent government regulations are expected to hamper growth of the global anticoagulant market.

Global Anticoagulant Market Trends:

There is an increase in demand for direct oral anticoagulants across the world. The development and introduction of direct oral anticoagulants (DOACs) represent a huge advancement in the field of anticoagulation. Moreover, the adoption of novel oral anticoagulants (NOACs) is increasing or has increased in developing countries, and is anticipated to show a similar trend over the forecast period owing to the high preference of NOACs over the warfarin.

Moreover, the use of anticoagulants is increasing, owing to the increasing usage of plasma in the pharmaceutical industry. Apart from this, they are being used in a variety of clinical applications. These wide-ranging applications range from anti-tumor and anti-inflammatory to the prevention of infectious disease and the use as nano-carriers for drug delivery. This trend is also expected to continue over the forecast period, driving the market growth.